Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 12/20 | 0.54 |
| ▸ | AVPR2 | P30518 | 12/20 | 0.54 |
| ▸ | AVPR1B | P47901 | 9/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6960321 | 0.95 | AVPR1A (0.52) | AVPR1AAVPR2AVPR1BHSD11B1PDCD1 | |
| SCHEMBL6964971 | 0.91 | AVPR2 (0.48) | AVPR1AAVPR2AVPR1B | |
| SCHEMBL6957577 | 0.90 | AVPR1A (0.49) | AVPR1AAVPR2AVPR1B | |
| SCHEMBL6968601 | 0.88 | AVPR2 (0.50) | AVPR1AAVPR2AVPR1B | |
| SCHEMBL6960071 | 0.87 | AVPR1A (0.53) | AVPR1AAVPR2AVPR1BPDCD1CD274 | |
| SCHEMBL6964451 | 0.87 | AVPR1A (0.49) | AVPR1AAVPR2AVPR1BPDCD1CD274 | |
| SCHEMBL6970362 | 0.85 | AVPR1A (0.49) | AVPR1AAVPR2AVPR1BPDCD1CD274 | |
| SCHEMBL9414294 | 0.85 | AVPR1A (0.47) | AVPR1AAVPR2AVPR1B | |
| SCHEMBL6970791 | 0.83 | AVPR2 (0.49) | AVPR1AAVPR2AVPR1B | |
| SCHEMBL6957855 | 0.82 | AVPR1A (0.54) | AVPR1AAVPR2AVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5521170-A | VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-28 | — | — | US | disclosed |
| EP-0620216-A1 | Benzamide derivatives and their use as vasopressin antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |